Adebrelimab Combined With Albumin Paclitaxel for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Jun 2025: Trial registered, NCT07007364

The trials

NCT07007364: Neoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for Early-Stage Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Trial

State
Under way
Phase
Phase 2
People
30 planned
Started
19 Jun 2025
Primary completion
1 Jun 2026
Arms
Neoadjuvant low-dose radiotherapy combined with adebrelimab and monotherapy with albumin paclitaxel
Results
None posted
  1. 5 Jun 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.